Structural insights into proprotein convertase activation facilitate the engineering of highly specific furin inhibitors. [PDF]
Klaushofer R +7 more
europepmc +1 more source
Genetic Pathogenesis of Abdominal Aortic Aneurysm and the Role of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9). [PDF]
Choi JY, Gwon JG.
europepmc +1 more source
Proprotein Convertase Subtilisin/Kexin Type 9 Induces Platelet-Derived Transforming Growth Factor-<i>β</i> to Promote Myocardial Fibrosis After Myocardial Infarction. [PDF]
Wang Q, Huang W, Xia D, Wang F, Nair S.
europepmc +1 more source
Optimization of 4-Amino-2-Pyridone Inhibitors of Proprotein Convertase Subtilisin/Kexin Type 9: Integrating Structure-Activity and Structure-Metabolism Relationships. [PDF]
Giannessi L +12 more
europepmc +1 more source
Dramatic Coronary Artery Aneurysm Regression After Coronary Artery Bypass Grafting and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy. [PDF]
Yokoyama Y +3 more
europepmc +1 more source
Decreasing Proprotein Convertase 5 Causes Hirschsprung's Disease by Disrupting Neural Crest Cell Migration. [PDF]
Liu Z +15 more
europepmc +1 more source
The Proprotein Convertase BLI-4 Is Required for Axenic Dietary Restriction Mediated Longevity in Caenorhabditis elegans. [PDF]
Wu P +3 more
europepmc +1 more source
Computer-aided design enables repurposing of proprotein convertase subtilisin/kexin type 9 degrader from cholesterol-lowering to colon cancer therapy. [PDF]
Fan G +6 more
europepmc +1 more source
Comment on: PACE4 (PCSK6): another proprotein convertase linked to iron homeostasis?
Alessia Pagani +5 more
doaj +1 more source
Gender differences in the plasma profiles of proprotein convertase subtilisin/kexin-type 9 (PCSK9), soluble low-density lipoprotein receptor (sLDLR), total cholesterol, and triglycerides in patients with colorectal cancer liver metastases: diagnostic and prognostic implications. [PDF]
Lafortune C +5 more
europepmc +1 more source

